US Patent Issued to Michael Naesby, IPTECTOR ASSETS on Sept. 22 for "Recombinant host cells with improved production of tetraketide derivatives" (French Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,189, issued on Sept. 22, was assigned to Michael Naesby (Huningue, France) and IPTECTOR ASSETS APS (Lynge, Denmark).

"Recombinant host cells with improved production of tetraketide derivatives" was invented by Michael Naesby (Huningue, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a recombinant microbial host cell producing a tetraketide or derivatives thereof from one or more substrates selected from cinnamoyl-CoA, p-Coumaroyl-CoA, Caffeoyl-CoA, Feruloyl-CoA, malonyl-CoA, sinapoyl-CoA and dihydro derivatives thereof, comprising an operative biosynthetic metabolic pathway for the tetraketide or derivatives t...